Biohaven Pharmaceutical Holding Company Ltd. Stock
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.99 USD | -1.89% | -75.04% | -74.97% |
May. 15 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
May. 14 | Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2020 | 63.63 | Sales 2021 | 462.51 | Capitalization | 9.03B |
---|---|---|---|---|---|
Net income 2020 | -767M | Net income 2021 | -847M | EV / Sales 2020 | 87,534,473 x |
Net Debt 2020 | 432M | Net Debt 2021 | 860M | EV / Sales 2021 | 21,377,123 x |
P/E ratio 2020 |
-6.56
x | P/E ratio 2021 |
-10.5
x | Employees | 928 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 90.13% |
1 day | -1.89% | ||
Current month | -74.97% | ||
Current year | -74.97% |
Managers | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 22-10-02 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 17-10-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 22-10-02 |
Gastón Ortega
BRD | Director/Board Member | - | 22-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.97% | 0 M€ | 0.00% | - | |
0.11% | 9 M€ | -.--% | - | |
0.06% | 744 M€ | +9.79% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 37.99 | -1.89% | 857,526 |
24-05-21 | 38.72 | -1.53% | 1,059,485 |
24-05-20 | 39.32 | +5.22% | 872,874 |
24-05-17 | 37.37 | -2.83% | 807,842 |
24-05-16 | 38.46 | +3.72% | 595,667 |
Delayed Quote Nyse, May 22, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-74.97% | 541M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- BHVN Stock